A randomized phase II study evaluating concurrent or sequential fixed-dose immune therapy in combination with cisplatin and intensity-modulated radiotherapy in intermediate- or high-risk, previously untreated, locally advanced head and neck cancer (LA SCCHN).

被引：0
|
作者：
Clump, David Anthony
Zandberg, Dan Paul
Skinner, Heath Devin
Ohr, James
Fenton, Moon Jung
Normolle, Daniel Paul
Beitler, Jonathan Jay
Bauman, Julie E.
Ferris, Robert L.
机构：
[1] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh Canc Inst, Seven Fields, PA USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA
[5] Univ Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6007
引用
收藏
页数：1
相关论文
共 45 条
  • [41] A Phase I//II Study of Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination with Regional Positive Lymph Node Intensity-Modulated Radiation Therapy for Locally Advanced Peripheral Non-Small Cell Lung Cancer
    Li, X.
    Bo, W. J.
    Lin, S.
    Zhang, J.
    Wen, Q.
    Yang, B.
    Ren, P.
    Pang, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E692 - E692
  • [42] Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.
    Oar, Andrew
    Kneebone, Andrew
    Lee, Mark
    Goldstein, David
    Sjoquist, Katrin Marie
    Le, Hien
    Chu, Julie
    Barbour, Andrew
    Gholamrezaei, Leily
    Lynam, James F.
    Bece, Andrej
    Bahamad, Sandra
    Yip, Sonia
    Espinoza, David
    Chantrill, Lorraine A.
    Moore, Alisha
    Lee, Dominique
    Nguyen, Quoc Nam
    Samra, Jaswinder
    Mumford, Jan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] The 3-Year Outcome of 3D High-Dose-Rate Brachytherapy in Combination With Regional Metastatic Lymph Nodes Intensity-Modulated Radiotherapy in Peripheral Locally Advanced Non-Small Cell Lung Cancer: A Phase I/II Clinical Trial
    Xiang, L.
    Wu, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E458 - E459
  • [44] High Dose [F-18]-Fluorodeoxyglucose (FDG) PET/CT Based Imaged-Guided Intensity-Modulated Radiotherapy (IG-IMRT) with Concurrent paclitaxel (P) and Carboplatin (C) in Locally Advanced Non-Small-Cell Lung Cancer (LANSCLC): A Dose-Finding Phase I Study
    Zhang, T.
    Zhao, G.
    Xu, Y.
    Liu, Y.
    Chen, Z.
    Cheng, N.
    Yan, G.
    Hu, Y.
    Chen, Y.
    Yao, S.
    Hu, Z.
    Chen, X.
    Chen, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S146 - S146
  • [45] A phase II noncomparative study of neoadjuvant (NA) chemohormone therapy (CHT), radical prostatectomy (RP), and postoperative radiotherapy (RT) in locally advanced (LA) high-risk prostate cancer (HRPC): A monoinstitutional 6-year experience with two NA CHT regimens
    Lo Re, G.
    Boccalon, M.
    Maruzzi, D.
    Bortolus, R.
    Lenardon, O.
    Marus, V.
    Rustici, C.
    Tumolo, S.
    Garbeglio, A.
    Sulfaro, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345